| scholarly article | Q13442814 |
| P50 | author | Lorenzo G. Mantovani | Q45351103 |
| Pietro Lampertico | Q45354169 | ||
| P2093 | author name string | Shehzad Ali | |
| Benedicte Lescrauwaet | |||
| Neil Hawkins | |||
| Stuart Mealing | |||
| Stefan Bjork | |||
| P2860 | cites work | Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 |
| Mixed treatment comparison meta-analysis evaluating the relative efficacy of nucleos(t)ides for treatment of nucleos(t)ide-naive patients with chronic hepatitis B. | Q33687721 | ||
| Simultaneous comparison of multiple treatments: combining direct and indirect evidence. | Q34081552 | ||
| Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. | Q34500537 | ||
| Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. | Q34621209 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons | Q37167644 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews | Q37433313 | ||
| Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B | Q42913700 | ||
| Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B. | Q46931662 | ||
| A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. | Q46981468 | ||
| Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom | Q80599225 | ||
| P433 | issue | 1 | |
| P921 | main subject | chronic hepatitis B | Q55779876 |
| P577 | publication date | 2013-01-24 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients | |
| P478 | volume | 3 |
| Q30988193 | Get real in individual participant data (IPD) meta-analysis: a review of the methodology |
| Q30251972 | GetReal in network meta-analysis: a review of the methodology |
| Q27016075 | The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis |
Search more.